Research illuminates a therapeutic strategy to induce cancer cell death

by Rachel Sauer,CU Anschutz Medical CampusCredit: CC0 Public DomainCancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors a

Updated on: January 22,2024

Research illuminates a therapeutic strategy to induce cancer cell death

by Rachel Sauer,CU Anschutz Medical CampusCredit: CC0 Public DomainCancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors a

Updated on:January 22,2024

Research suggests natural compound could be promising new alternative treatment for colon cancer

FEBRUARY 26, 2024byUniversity of PortsmouthSchisandrin B inhibits the proliferation of human colon cancer cells. Credit:ACS Pharmacology & Translational Science(2024). DOI: 10.10

Updated on: March 27,2024

Research suggests natural compound could be promising new alternative treatment for colon cancer

FEBRUARY 26, 2024byUniversity of PortsmouthSchisandrin B inhibits the proliferation of human colon cancer cells. Credit:ACS Pharmacology & Translational Science(2024). DOI: 10.10

Updated on:March 27,2024

New circulating tumor DNA test measures multiple markers to detect cancer early

byeLifeCredit: CC0 Public DomainResearchers have developed a method that simultaneously measures different cancer-specific hallmarks of DNA circulating in the blood, aiding early detection and l

Updated on: January 12,2024

New circulating tumor DNA test measures multiple markers to detect cancer early

byeLifeCredit: CC0 Public DomainResearchers have developed a method that simultaneously measures different cancer-specific hallmarks of DNA circulating in the blood, aiding early detection and l

Updated on:January 12,2024

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

Updated on: April 29,2025

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

Updated on:April 29,2025

Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid e

Updated on: March 30,2024

Breast cancer patients can safely avoid extensive removal of lymph nodes if they respond well to systemic treatment

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainPatients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid e

Updated on:March 30,2024

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on: December 01,2024

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on:December 01,2024

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on: September 30,2024

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on:September 30,2024

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on: April 01,2024

Tracking a rare and dangerous breast cancer

by Angela Spivey,Duke UniversityGayathri Devi, PhD, studies how inflammatory breast cancer cells are able to evade the body’s programmed cell death mechanisms that normally get rid of damaged or

Updated on:April 01,2024

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja

Updated on: May 07,2024

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja

Updated on:May 07,2024

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030

Updated on: January 26,2024

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030

Updated on:January 26,2024

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin

Updated on: April 28,2024

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin

Updated on:April 28,2024

Researchers block two cancer cell signaling pathways and slow tumor growth

by Case Western Reserve UniversityBlocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in t

Updated on: June 01,2024

Researchers block two cancer cell signaling pathways and slow tumor growth

by Case Western Reserve UniversityBlocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in t

Updated on:June 01,2024